News

Maruti Suzuki share price gained nearly 1 per cent in Wednesday's trading session (June 4) after the carmaker announced the ...
Shares of Sun Pharma Advanced Research Company Ltd (SPARC) plunged nearly 20% on Wednesday on the NSE, after the company ...
SPARC share price plunged 20% following poor Phase 2 trial outcomes for SCD-044. The stock peaked at ₹186 but fell to ₹156.50 during trading on the BSE.
SPARC tumbled 19 percent after Phase 2 trials of its psoriasis drug SCD-044 failed to meet primary endpoints. The company ...
Too much sun can do more than turn your skin red or brown—it can actually make you sick. About the experts Farah Moustafa, MD ...
8% of patients maintained that the ongoing war had affected the quality of the treatment they are receiving for psoriasis.
Here comes the sunscreen—and the hats, and the protective clothing. For our edit of the year’s very best, we joined forces ...
NOW the sun is out, your SPF should be too. Did you know we are recommended to use two shot glasses worth of suncream to cover our body? It might seem excessive, but no patch should be left ...
The bacteria that live on your skin could be playing a role in protecting you from the sun's harmful UV rays, scientists have ...
The best spray sunscreens are a handy addition to any skin-care stash, offering a convenient, refreshing way to spritz your ...
Sun Pharmaceutical , India's largest drugmaker by revenue, reported a bigger adjusted quarterly profit on Thursday, driven by ...
In psoriasis patients, inflammation can persist internally even after skin symptoms improve with biologic treatments, potentially contributing to broader health problems such as obesity ...